-
Camostat Mesilate and Translational Inhibition Logic
2026-08-18
A mechanistic and strategic guide to using Camostat Mesilate across ENaC biology, plasmin–TGF-β signaling, hepatic fibrosis models, and assay-informed translational research—while distinguishing protease inhibition from structure-guided antiviral PPI design.
-
Osteoblast ECM1 and Enzalutamide Resistance
2026-08-18
The reference study identifies osteoblast-derived ECM1 as a microenvironmental driver of enzalutamide resistance in bone metastatic prostate cancer. It connects ECM1 to ENO1 phosphorylation, GRB2/SOS1 recruitment, and MAPK activation, while showing that ECM1 or ENO1 inhibition can restore anti-androgen sensitivity.
-
Oltipraz Workflows for Nrf2 and MASLD Research
2026-08-17
Build a controlled Nrf2 induction workflow with Oltipraz to connect phase II enzyme responses with autophagy, ferroptosis, lipid stress, and liver injury readouts. The defined small molecule complements complex botanical interventions by making concentration, timing, and pathway attribution easier to test.
-
X-Gal Workflows for Cloning and Reporter Validation
2026-08-17
Use X-Gal as a fast visual checkpoint for blue-white colony screening, plasmid quality control, and qualitative β-galactosidase reporter workflows. This guide connects practical molecular cloning decisions with findings from olfactory receptor research while clearly separating established use from exploratory assay design.
-
Azithromycin B1398: Reliable Assay Design
2026-08-16
Azithromycin B1398 supports controlled bacterial infection research, resistance testing, and carefully interpreted viability workflows. This scenario-based guide explains mechanism, solvent compatibility, concentration selection, data interpretation, and practical supplier evaluation.
-
EZ Cap Cy5 Firefly Luciferase mRNA Workflows
2026-08-15
Pair direct Cy5 visualization with Firefly Luciferase output to separate delivery, intracellular trafficking, and protein expression in one experiment. This practical guide shows how to use a Cap1-capped, 5-moUTP modified mRNA reporter to optimize carriers, compare transfection conditions, and interpret discordant fluorescence and bioluminescence signals.
-
Spatial Disease Defense in Ambrosia Beetle Nests
2026-08-14
Masoudi, Joseph, and Keyhani show that spatial organization and fungal antagonism can buffer disease transmission in social ambrosia beetle colonies. Their findings suggest that nest location, contact structure, brood placement, and microbial interactions jointly protect colony reproduction even when an insect-pathogenic fungus is present.
-
Social Nest Architecture Limits Beetle Disease Spread
2026-08-14
A 2025 iScience study shows that spatial organization within Xyleborus affinis nests can limit fungal disease exposure to brood, even when infected adults remain in close contact with nestmates. The work combines infection experiments, spatial mapping, colony-performance measurements, and fungal interaction assays to identify nest structure and a Neocosmospora symbiont as complementary defenses.
-
Vitamin C in HEV Organoid Assay Design
2026-08-13
Use Vitamin C (ascorbic acid) as a controlled redox and cytotoxicity perturbation in multilineage organoids, while keeping its established anticancer evidence separate from emerging antiviral questions. This workflow connects CT26 tumor assays with liver, intestinal, and brain organoid models to improve dose selection, endpoint interpretation, and troubleshooting in cancer research and HEV studies.
-
MG-132 Workflows for Proteostasis and p53 Studies
2026-08-13
Use MG-132 (Z-LLL-al) to connect acute proteasome blockade with protein accumulation, oxidative stress, apoptosis, and cell-cycle phenotypes. This workflow also shows how to use the compound as a functional perturbation when studying the MLF2–USP7–p53 axis in colorectal cancer models.
-
FAISL Stabilizes FAK in Triple-Negative Breast Cancer
2026-08-12
This study identifies FAISL as a long noncoding RNA that stabilizes focal adhesion kinase by blocking Calpain 2-mediated proteolysis, thereby promoting triple-negative breast cancer adhesion, survival, progression, and metastasis. Its combination of transcriptomic discovery, RNA–protein interaction analysis, mechanistic proteolysis assays, and nanoparticle-mediated RNA interference establishes FAISL as a potentially actionable regulator of FAK signaling.
-
AMPK, ULK1, and Energy Stress in Autophagy
2026-08-12
The reference study challenges the prevailing view that AMPK universally activates autophagy during glucose deprivation. Its cell-based evidence shows that AMPK suppresses ULK1 initiation signaling during acute energy stress while protecting the autophagy machinery from caspase-mediated loss, thereby separating short-term restraint from later recovery.
-
ARCA Cy5 EGFP mRNA (5-moUTP) Guide
2026-08-11
Learn how ARCA Cy5 EGFP mRNA (5-moUTP), SKU R1009, helps separate delivery, translation, and cell-health effects in mammalian assays. This scenario-based guide covers experimental design, handling, interpretation, and practical product selection for reproducible mRNA delivery studies.
-
2X Taq PCR Master Mix for SPVD Assays
2026-08-11
Learn how 2X Taq PCR Master Mix (with dye) can complement image-based sweetpotato virus disease screening. This article connects deep-learning lesion segmentation with practical PCR confirmation, assay controls, and TA-cloning decisions.
-
Circular RNA Neoantigen Vaccines for HCC
2026-08-10
The reference study develops a circular RNA vaccine encoding hepatocellular carcinoma neoantigens and links RNA circularization with sustained expression, dendritic-cell activation, and antitumor T-cell responses. Its lipid nanoparticle delivery strategy produced therapeutic and preventive activity in murine tumor models, while also highlighting the experimental steps needed before translation to personalized cancer immunotherapy.